Literature DB >> 7007514

New method for production of influenza A virus subtype specific antisera: employment of precipitate obtained by crossed immunoelectrophoretic techniques as antigen.

A Hornsleth, C H Mordhorst, I R Pedersen.   

Abstract

The crossed immunoelectrophoretic technique was employed for the production of subtype-specific influenza A virus antisera. Glycoprotein-containing precipitates were produced by this technique by using detergent solubilized influenza A virus glycoproteins as antigens in the first dimension gel and rabbit antisera against these antigens in the second dimension gel. By cutting these precipitates out of the gel and using them for the immunization of rabbits, antisera were produced which showed the presence of subtype-specific antibodies in haemagglutination inhibition and immunofluorescent antibody tests but no antibodies in neuraminidase inhibition tests.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7007514     DOI: 10.1016/0022-1759(80)90298-7

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  4 in total

1.  Characterization of a major antigenic component of Aspergillus fumigatus.

Authors:  C Harvey; J L Longbottom
Journal:  Clin Exp Immunol       Date:  1986-07       Impact factor: 4.330

2.  Detection of respiratory syncytial virus in nasopharyngeal secretions by inhibition of enzyme-linked immunosorbent assay.

Authors:  A Hornsleth; E Brenøe; B Friis; F U Knudsen; P Uldall
Journal:  J Clin Microbiol       Date:  1981-11       Impact factor: 5.948

3.  Production of antiserum to respiratory syncytial virus polypeptides: application in enzyme-linked immunosorbent assay.

Authors:  A Hornsleth; P C Grauballe; B Friis; J Genner; I R Pedersen
Journal:  J Clin Microbiol       Date:  1981-11       Impact factor: 5.948

Review 4.  Crossed immunoelectrophoresis: qualitative and quantitative considerations.

Authors:  M Emmett; A J Crowle
Journal:  J Immunol Methods       Date:  1982       Impact factor: 2.303

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.